Salinomycin Hydroxamic Acids: Synthesis, Structure, and Biological Activity of Polyether Ionophore Hybrids

ACS Medicinal Chemistry Letters

Volumn 7, Issue 6, 2016, Pages 635-640

  Borgström, Björn ^a   Huang, Xiaoli ^a   Chygorin, Eduard ^a   Oredsson, Stina ^a   Strand, Daniel ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

ALDH+; head to tail conformation; hydroxamic acid derivative; salinomycin

Indexed keywords

HYDROXAMIC ACID DERIVATIVE; IONOPHORE; POLYETHER; SALINOMYCIN;

ALKYLATION; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER STEM CELL; COMPLEX FORMATION; CONFORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; NANOENCAPSULATION; PHENOTYPE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 84974589178     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.6b00079     Document Type: Article

References (55)

1. Suzuki, J.; Yasui, Y. Hybrid Natural Products. In Natural Products in Medicinal Chemistry; Hanessian, S. K., Ed.; Wiley-VCH Verlag GmbH.: Weinheim, Germany, 2014; pp 441-472.
2. Gademann, K. Natural product hybrids Chimia 2006, 60, 841-845 10.2533/chimia.2006.841
3. Tietze, L. F.; Bell, H. P.; Chandrasekhar, S. Natural product hybrids as new leads for drug discovery Angew. Chem., Int. Ed. 2003, 42, 3996-4028 10.1002/anie.200200553
4. Chen, C.; Li, X.; Neumann, C. S.; Lo, M. M.-C.; Schreiber, S. L. Convergent diversity-oriented synthesis of small-molecule hybrids Angew. Chem., Int. Ed. 2005, 44, 2249-2252 10.1002/anie.200462798
5. Reddy, B. G.; Vankar, Y. D. The synthesis of hybrids of D-galactose with 1-deoxynojirimycin analogues as glycosidase inhibitors Angew. Chem., Int. Ed. 2005, 44, 2001-2004 10.1002/anie.200462413
6. Kaliappan, K. P.; Ravikumar, V. Design and synthesis of novel sugar-oxasteroid-quinone hybrids Org. Biomol. Chem. 2005, 3, 848-851 10.1039/b418659a
7. Larsen, L.; Benn, M. H.; Parvez, M.; Perry, N. B. A cytotoxic triketone-phloroglucinol-bullatenone hybrid from Lophomyrtus bullata Org. Biomol. Chem. 2005, 3, 3236-3241 10.1039/b509076h
8. Hanessian, S.; Kothakonda, K. K. 3-N,N-Dimethylamino-3-deoxy lincomycin: A structure-based hybrid between lincomycin and the desosamine unit of erythromycin Bioorg. Med. Chem. 2005, 13, 5283-5288 10.1016/j.bmc.2005.05.070
9. álvaro, E.; de la Torre, M. C.; Sierra, M. A. The Nicholas approach to natural product hybrids Chem.-Eur. J. 2006, 12, 6403-6411 10.1002/chem.200600136
10. álvaro, E.; de la Torre, M. C.; Sierra, M. A. Synthesis of polymetallic macrocyclic terpene-derived hybrids Chem. Commun. 2006, 9, 985-987 10.1039/b515270d
11. Doddi, V. R.; Kokatla, H. P.; Pal, A. P. J.; Basak, R. K.; Vankar, Y. D. Synthesis of hybrids of D-glucose and D-galactose with pyrrolidine-based iminosugars as glycosidase inhibitors Eur. J. Org. Chem. 2008, 2008, 5731-5739 10.1002/ejoc.200800770
12. Paterson, I.; Naylor, G. J.; Wright, A. E. Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide Chem. Commun. 2008, 2008, 4628-4630 10.1039/b811575c
13. Wach, J.-Y.; Bonazzi, S.; Gademann, K. Antimicrobial surfaces through natural product hybrids Angew. Chem., Int. Ed. 2008, 47, 7123-7126 10.1002/anie.200801570
14. Sharma, M.; Chauhan, K.; Shivahare, R.; Vishwakarma, P.; Suthar, M. K.; Sharma, A.; Gupta, S.; Saxena, J. K.; Lal, J.; Chandra, P.; Kumar, B.; Chauhan, P. M. S. Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agents J. Med. Chem. 2013, 56, 4374-4392 10.1021/jm400053v
15. Fuwa, H.; Noto, K.; Kawakami, M.; Sasaki, M. Synthesis and biological evaluation of aspergillide A/neopeltolide chimeras Chem. Lett. 2013, 42, 1020-1022 10.1246/cl.130322
16. Garai, S.; Mehta, G. Total synthesis of bioactive drimane-epoxyquinol hybrid natural products: macrophorin A, 4′-oxomacrophorin A, and 1′-epi-craterellin A Tetrahedron Lett. 2014, 55, 6252-6256 10.1016/j.tetlet.2014.09.075
17. 5 using 1,3-dipolar cycloaddition reactions J. Org. Chem. 2014, 79, 10786-10800 10.1021/jo5016745
18. Jürjens, G.; Kirschning, A. Synthesis of a cytotoxic ansamycin hybrid Org. Lett. 2014, 16, 3000-3003 10.1021/ol5011278
19. Kinashi, H.; Ōtake, N.; Yonehara, H.; Sato, S.; Saito, Y. The structure of salinomycin, a new member of the polyether antibiotics Tetrahedron Lett. 1973, 14, 4955-4958 10.1016/S0040-4039(01)87382-2
20. Borgström, B.; Huang, X.; Pošta, M.; Hegardt, C.; Oredsson, S.; Strand, D. Synthetic modification of salinomycin: selective O-acylation and biological evaluation Chem. Commun. 2013, 49, 9944-9946 10.1039/c3cc45983g
21. Gupta, P. B.; Onder, T. T.; Jiang, G.; Tao, K.; Kuperwasser, C.; Weinberg, R. A.; Lander, E. S. Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 2009, 138, 645-659 10.1016/j.cell.2009.06.034
22. Huang, X.; Borgström, B.; Kempengren, S.; Persson, L.; Hegardt, C.; Strand, D.; Oredsson, S. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs BMC Cancer 2016, 16, 145 10.1186/s12885-016-2142-3
23. Huang, X.; Borgström, B.; Månsson, L.; Persson, L.; Oredsson, S.; Hegardt, C.; Strand, D. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues ACS Chem. Biol. 2014, 9, 1587-1594 10.1021/cb5002153
24. Woeller, C. F.; O'Loughlin, C. W.; Roztocil, E.; Feldon, S. E.; Phipps, R. P. Salinomycin and other polyether ionophores are a new class of antiscarring agent J. Biol. Chem. 2015, 290, 3563-3575 10.1074/jbc.M114.601872
25. Antoszczak, M.; Maj, E.; Stefańska, J.; Wietrzyk, J.; Janczak, J.; Brzezinski, B.; Huczyński, A. Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin Bioorg. Med. Chem. Lett. 2014, 24, 1724-1729 10.1016/j.bmcl.2014.02.042
26. Antoszczak, M.; Maj, E.; Napiórkowska, A.; Stefańska, J.; Augustynowicz-Kopeć, E.; Wietrzyk, J.; Janczak, J.; Brzezinski, B.; Huczyński, A. Synthesis, Anticancer and Antibacterial Activity of Salinomycin N-Benzyl Amides Molecules 2014, 19, 19435-19459 10.3390/molecules191219435
27. Antoszczak, M.; Popiel, K.; Stefańska, J.; Wietrzyk, J.; Maj, E.; Janczak, J.; Michalska, G.; Brzezinski, B.; Huczyński, A. Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic-salinomycin Eur. J. Med. Chem. 2014, 76, 435-444 10.1016/j.ejmech.2014.02.031
28. Huczyński, A.; Janczak, J.; Stefańska, J.; Antoszczak, M.; Brzezinski, B. Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic-salinomycin Bioorg. Med. Chem. Lett. 2012, 22, 4697-4702 10.1016/j.bmcl.2012.05.081
29. Huczyński, A.; Antoszczak, M.; Kleczewska, N.; Lewandowska, M.; Maj, E.; Stefańska, J.; Wietrzyk, J.; Janczak, J.; Celewicz, L. Synthesis and biological activity of salinomycin conjugates with floxuridine Eur. J. Med. Chem. 2015, 93, 33-41 10.1016/j.ejmech.2015.01.045
30. Antonenko, Y. N.; Rokitskaya, T. I.; Huczyński, A. Electrogenic and nonelectrogenic ion fluxes across lipid and mitochondrial membranes mediated by monensin and monensin ethyl ester Biochim. Biophys. Acta, Biomembr. 2015, 1848, 995-1004 10.1016/j.bbamem.2015.01.005
31. łowicki, D.; Huczyński, A. Structure and antimicrobial properties of monensin A and its derivatives: Summary of the achievements BioMed Res. Int. 2012, 2013, 1 10.1155/2013/742149
32. Pace, S. J.; Wang, C. Monensin amides for sodium-selective electrodes. U.S. Patent 5.522.978A, Jun 4, 1996.
33. Ling, Y.; Wang, X.; Wang, C.; Xu, C.; Zhang, W.; Zhang, Y.; Zhang, Y. Hybrids from farnesylthiosalicylic acid and hydroxamic acid as dual ras-related signaling and histone deacetylase (HDAC) inhibitors: Design, synthesis and biological Evaluation ChemMedChem 2015, 10, 971-976 10.1002/cmdc.201500019
34. Tang, C.; Li, C.; Zhang, S.; Hu, Z.; Wu, J.; Dong, C.; Huang, J.; Zhou, H.-B. Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer J. Med. Chem. 2015, 58, 4550-4572 10.1021/acs.jmedchem.5b00099
35. Xiao, Z.-P.; Peng, Z.-Y.; Dong, J.-J.; Deng, R.-C.; Wang, X.-D.; Ouyang, H.; Yang, P.; He, J.; Wang, Y.-F.; Zhua, M.; Peng, X.-C.; Peng, W.-X.; Zhu, H.-L. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors Eur. J. Med. Chem. 2013, 68, 212-221 10.1016/j.ejmech.2013.07.047
36. de Jesús, J.; Marinero, C.; Lapierre, M.; Cavaillès, V.; Saint-Fort, R.; Vessières, A.; Top, S.; Jaouen, G. Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species Dalton Trans. 2013, 42, 15489-15501 10.1039/c3dt51917a
37. Jiang, B.; Huang, X.; Yao, H.; Jiang, J.; Wu, X.; Jiang, S.; Wang, Q.; Lue, T.; Xu, J. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase Org. Biomol. Chem. 2014, 12, 2114-2127 10.1039/c3ob41936c
38. Bogatyrenko, T. N.; Konovalova, N. P.; Sipyagin, A. M.; Bogatyrenko, V. R.; Kuropteva, Z. V.; Baider, L. M.; Sashenkova, T. E.; Fedorov, B. S. Polyfunctional action of biologically active compounds in antitumor chemotherapy of cyclophosphamide Russ. Chem. Bull. 2014, 63, 1187-1191 10.1007/s11172-014-0570-2
39. For lead reference see: Miller, M. J. Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogs Chem. Rev. 1989, 89, 1563-1579 10.1021/cr00097a011
40. Yue, P.; Lopez-Tapia, F.; Paladino, D.; Li, Y.; Chen, C.-H.; Hilliard, T.; Chen, Y.; Tius, M. A.; Turkson, J. Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo Cancer Res. 2016, 76, 652 10.1158/0008-5472.CAN-14-3558
41. Marks, P. A.; Rifkind, R. A.; Richon, V. M.; Breslow, R.; Miller, T.; Kelly, W. K. Histone deacetylases and cancer: causes and therapies Nature Rev. Cancer 2001, 1, 194-202 10.1038/35106079
42. For a study of combination effects from hydroxamic acid HDAC inhibitor and SA, see: Booth, L.; Roberts, J. L.; Conley, A.; Cruickshanks, N.; Ridder, T.; Grant, S.; Poklepovic, A.; Dent, P. HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells Cancer Biol. Ther. 2014, 15, 305-316 10.4161/cbt.27309
43. Patel, D. V.; Young, M. G.; Robinson, S. P.; Hunihan, L.; Dean, B. J.; Gordon, E. M. Hydroxamic acid-based bisubstrate analog inhibitors of ras farnesyl protein transferase J. Med. Chem. 1996, 39, 4197-4210 10.1021/jm960190h
44. Ballatore, C.; Huryn, D. M.; Smith, A. B., III Carboxylic acid (bio)isosteres in drug design ChemMedChem 2013, 8, 385-395 10.1002/cmdc.201200585
45. Yoganathan, S.; Yin, N.; He, Y.; Mesleh, M. F.; Gu, Y. G.; Miller, S. J. An efficient chemical synthesis of carboxylate-isostere analogs of daptomycin Org. Biomol. Chem. 2013, 11, 4680-4685 10.1039/c3ob40924d
46. Xu, X.; Chai, S.; Wang, P.; Zhang, C.; Yang, Y.; Yang, Y.; Wang, K. Aldehyde dehydrogenases and cancer stem cells Cancer Lett. 2015, 369, 50-57 10.1016/j.canlet.2015.08.018
47. Ginestier, C.; Hur, M. H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C. G.; Liu, S.; Schott, A.; Hayes, D.; Birnbaum, D.; Wicha, M. S.; Dontu, G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 2007, 1, 555-567 10.1016/j.stem.2007.08.014
48. For hydroxamic acid syntheses, see refs 48 and 49. Porcheddu, A.; Giacomelli, G. Synthesis of Oximes and Hydroxamic Acids. In The Chemistry of Hydroxylamines, Oximes and Hydroxamic Acids; Rappapport, Z.; Liebman, Eds.; Wiley-VCH Verlag GmbH.: Weinheim, Germany, 2009; pp 163-231.
49. Yale, H. L. The hydroxamic acids Chem. Rev. 1943, 33, 209-256 and references therein 10.1021/cr60106a002
50. - Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. 1978, 34, 110-115 10.1107/S056774087800240X
51. Huczyński, A.; Janczak, J.; łowicki, D.; Brzezinski, B. Monensin A acid complexes as a model of electrogenic transport of sodium cation Biochim. Biophys. Acta, Biomembr. 2012, 1818, 2108-2119 10.1016/j.bbamem.2012.04.017
52. Paulus, E. F.; Kurz, M.; Matter, H.; Vértesy, L. Solid-state and solution structure of the salinomycin-sodium complex: Stabilization of different conformers for an ionophore in different environments J. Am. Chem. Soc. 1998, 120, 8209-8221 10.1021/ja973607x
53. Jenks, W. P. The reaction of hydroxylamine with activated acyl groups. I. Formation of O-acylhydroxylamine J. Am. Chem. Soc. 1958, 80, 4581-4584 10.1021/ja01550a040
54. Nikishin, G. I.; Troyansky, E. I.; Svitanko, I. V.; Chizhov, O. S. N,O-acylotropy in N-methylpentanehydroxamic acid Tetrahedron Lett. 1984, 25, 97-98 10.1016/S0040-4039(01)91158-X
55. Kinashi, H.; Ōtake, N.; Yonehara, H. Studies on the ionophorous antibiotics I. The crystal and molecular structure of salinomycin p-iodophenacyl ester Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. 1975, B31, 2411-2415 10.1107/S0567740875007716